Cargando…
Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P‐Glycoprotein Activities
Precision dosing strategies require accounting for between‐patient variability in pharmacokinetics together with subsequent pharmacodynamic differences. Liquid biopsy is a valuable new approach to diagnose disease prior to the appearance of clinical signs and symptoms, potentially circumventing inva...
Autores principales: | Achour, Brahim, Gosselin, Pauline, Terrier, Jean, Gloor, Yvonne, Al‐Majdoub, Zubida M., Polasek, Thomas M., Daali, Youssef, Rostami‐Hodjegan, Amin, Reny, Jean‐Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313840/ https://www.ncbi.nlm.nih.gov/pubmed/35262906 http://dx.doi.org/10.1002/cpt.2576 |
Ejemplares similares
-
Impact of SARS‐CoV‐2 Infection (COVID‐19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail
por: Lenoir, Camille, et al.
Publicado: (2021) -
Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of Drugs
por: Daali, Youssef, et al.
Publicado: (2022) -
Non-uniformity of Changes in Drug-Metabolizing Enzymes
and Transporters in Liver Cirrhosis: Implications for Drug Dosage
Adjustment
por: El-Khateeb, Eman, et al.
Publicado: (2021) -
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting
por: Lenoir, Camille, et al.
Publicado: (2022) -
Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis
por: Vasilogianni, Areti‐Maria, et al.
Publicado: (2022)